← Back to Clinical Trials
Recruiting NCT05135949

NCT05135949 Strength After Elbow Fractures in the Elderly

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05135949
Status Recruiting
Phase
Sponsor Fraser Orthopaedic Research Society
Condition Fracture;Elbow
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2021-02-22
Primary Completion 2027-02-01

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Patient Reported OutcomesStrength Test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2021-02-22 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.

Eligibility Criteria

Inclusion Criteria: 1. ≥65 years of age 2. Mayo type II olecranon fracture 3. Ambulatory (with or without the use of walking aides) Exclusion Criteria: 1. Additional injuries to the affected arm or contralateral arm 2. Associated nerve injury 3. Dementia or cognitive impairment that inhibits the collection of outcome measures 4. Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.) 5. Injury or previous deficit to the contralateral arm 6. Currently enrolled in any other research study involving drugs or medical devices 7. Open fractures 8. Inability to provide informed consent

Contact & Investigator

Central Contact

Kyrsten Butterfield, BSc

✉ kyrsten.butterfield@fraserhealth.ca

📞 604-553-3247

Principal Investigator

Farhad Moola, PhD

PRINCIPAL INVESTIGATOR

Orthopaedic Surgeon

Frequently Asked Questions

Who can join the NCT05135949 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Fracture;Elbow. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05135949 currently recruiting?

Yes, NCT05135949 is actively recruiting participants. Contact the research team at kyrsten.butterfield@fraserhealth.ca for enrollment information.

Where is the NCT05135949 trial being conducted?

This trial is being conducted at New Westminster, Canada.

Who is sponsoring the NCT05135949 clinical trial?

NCT05135949 is sponsored by Fraser Orthopaedic Research Society. The principal investigator is Farhad Moola, PhD at Orthopaedic Surgeon. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology